Skip to main content

Table 1 Basic clinical characteristics of the study population

From: Relationship between blood urea nitrogen to serum albumin ratio and short-term mortality among patients from the surgical intensive care unit: a population-based real-world study

Characteristic

Total

(n = 2,686)

Death group

(n = 638)

Survival group

(n = 2,048)

t/Z/χ2 value

P value

Age (years)

63.13 ± 16.60

69.06 ± 15.61

61.29 ± 16.47

-10.528

< 0.001

Male, n (%)

1,489 (55.44)

343 (53.76)

1,146 (55.96)

0.949

0.330

SOFA (score)

5.93 ± 4.00

7.65 ± 4.41

5.39 ± 3.70

-12.834

< 0.001

SAPS II (score)

37.10 ± 14.44

45.42 ± 14.68

34.52 ± 13.35

-17.574

< 0.001

BUN (mg/dL)

18 (12,28)

23 (15,39)

17 (12,2)

-10.746

< 0.001

Albumin (g/dL)

3.20 ± 0.67

3.09 ± 0.70

3.23 ± 0.66

4.593

< 0.001

B/A

5.52 (3.67,9.69)

7.47 (4.58,13.46)

5.15 (3.41,8.41)

-10.798

< 0.001

WBC (× 109/L)

10.70 (7.50,14.80)

11.95 (8.80,16.70)

10.40 (7.30,14.20)

-6.655

< 0.001

Hemoglobin (g/L)

111.45 ± 22.71

107.57 ± 23.75

112.65 ± 22.24

4.958

< 0.001

Hematocrit (%)

33.42 ± 6.55

32.60 ± 6.95

33.68 ± 6.40

3.628

< 0.001

Platelet (× 109/L)

192 (135,264)

185 (122,254)

194 (139,266)

2.204

0.028

Creatinine (umol/L)

79.56 (61.88,114.92)

97.24 (70.72,159.12)

79.56 (61.88,106.08)

-7.929

< 0.001

Bicarbonate (mmol/L)

22.68 ± 4.60

21.90 ± 5.22

22.92 ± 4.36

4.897

< 0.001

Glucose (mmol/L)

8.22 ± 3.81

8.46 ± 4.10

8.14 ± 3.72

-1.861

0.063

Total calcium (mmol/L)

2.09 ± 0.25

2.09 ± 0.23

2.09 ± 0.26

-0.005

0.996

Phosphorus (mmol/L)

1.19 ± 0.46

1.25 ± 0.53

1.17 ± 0.43

-3.673

< 0.001

Magnesium (mmol/L)

0.79 ± 0.16

0.81 ± 0.17

0.78 ± 0.16

-4.840

< 0.001

Chlorine (mmol/L)

103.81 ± 6.31

103.43 ± 7.20

103.93 ± 6.00

1.751

0.080

Potassium (mmol/L)

4.12 ± 0.77

4.24 ± 0.87

4.08 ± 0.74

-4.540

< 0.001

Sodium (mmol/L)

137.98 ± 5.27

137.95 ± 6.21

137.99 ± 4.95

0.165

0.869

MV, n (%)

1,828 (68.06)

513 (80.41)

1,315 (64.21)

58.714

< 0.001

Comorbidities, n (%)

 Hypertension

1,178 (43.86)

295 (46.24)

883 (43.12)

1.927

0.165

 Diabetes

719 (26.77)

176 (27.59)

543 (26.51)

0.286

0.593

 ARF

675 (25.13)

266 (41.69)

409 (19.97)

121.996

 < 0.001

 Atrial fibrillation

608 (22.64)

214 (33.54)

394 (19.24)

56.836

 < 0.001

 Cirrhosis

459 (17.09)

128 (20.06)

331 (16.16)

5.224

0.022

 CKD

390 (14.52)

122 (19.12)

268 (13.09)

14.281

< 0.001

 Malignancy

526 (19.58)

153 (23.98)

373 (18.21)

10.278

0.001

 AMI

116 (4.32)

38 (5.96)

78 (3.81)

5.429

0.020

 SAH

224 (8.34)

69 (10.82)

155 (7.57)

6.708

0.010

 Acute pancreatitis

67 (2.49)

15 (2.35)

52 (2.54)

0.071

0.790

 Sepsis

1,658 (61.73)

454 (71.16)

1,204 (58.79)

31.512

< 0.001

 Peripheral vascular disease

236 (8.79)

76 (11.91)

160 (7.81)

10.202

< 0.001

 Severe liver disease

403 (15.00)

124 (19.44)

279 (13.62)

12.888

< 0.001

 AKI

1682 (62.62)

487 (76.33)

1195 (58.35)

67.206

< 0.001

 Peptic ulcer disease

74 (2.76)

21 (3.29)

53 (2.59)

0.899

0.343

 Paraplegia

328 (12.21)

106 (16.61)

222 (10.84)

15.131

< 0.001

Length of ICU stay (days)

3.62 (1.95,7.76)

5.04 (2.42,10.16)

3.17 (1.89,6.86)

-7.520

< 0.001

Length of hospital stay (days)

10.31 (6.13,18.58)

10.75 (4.96,18.79)

10.19 (6.52,18.54)

2.023

0.043

  1. SOFA sequential organ failure assessment, SAPS II simplified acute physiology score II, WBC white blood cell, BUN blood urea nitrogen, B/A blood urea nitrogen to serum albumin ratio, MV mechanical ventilation, ARF acute respiratory failure, CKD chronic kidney disease, AMI acute myocardial infarction, SAH subarachnoid hemorrhage, AKI acute kidney injury, ICU intensive care unit